FDA and CDC Considering , 'Approval' of a Fourth COVID Shot , for People Over 50.
Poynter reports that United States citizens over 50 could be approved to receive a fourth dose of COVID vaccination as early as this week.
.
The Food and Drug Administration and Centers for Disease Control and Prevention are reportedly considering a “permissive recommendation” for a fourth dose.
.
The move would fall short of a full recommendation, instead just allowing people who wish to receive an additional booster to get one.
.
Granting a “permissive recommendation” allows the FDA to skip the special review panels required to grant the fourth dose full approval.
.
Granting a “permissive recommendation” allows the FDA to skip the special review panels required to grant the fourth dose full approval.
.
According to Poynter, the review panel that determines the efficacy and safety of drugs is not scheduled to meet until April.
.
According to Poynter, the review panel that determines the efficacy and safety of drugs is not scheduled to meet until April.
.
At that time, the panel will take up the topic of who should be eligible for a fourth dose in 2022.
.
According to Poynter, one of the main issues regarding boosters is a matter of timing.
.
Anyone receiving a booster now runs the risk of protection fading by the time a possible fall/winter resurgence of COVID rolls around.
.
Poynter reports that health experts consider a surge in the fall of 2022 to be "highly likely.".
Currently, drug companies are working to create vaccine formulas that would be effective against different variants of the coronavirus.
